<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03210831</url>
  </required_header>
  <id_info>
    <org_study_id>NCH-00000631</org_study_id>
    <nct_id>NCT03210831</nct_id>
  </id_info>
  <brief_title>Early Predictors of Necrotizing Enterocolitis in Neonates</brief_title>
  <official_title>Clinical Model for Early Predictors of Necrotizing Enterocolitis in Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this project is to identify neonates who are predisposed to Necrotizing&#xD;
      Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive&#xD;
      measures as well as biochemical markers to identify neonates early in the disease process.&#xD;
      Thus, the investigators aim to identify infants with NEC prior to the onset of symptoms to&#xD;
      institute or test treatments in the long term to prevent the progression of the disease in&#xD;
      these infants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will enroll premature, low birth weight infants in the Neonatal Intensive Care&#xD;
      Units (NICU). Potential study subjects will be identified upon delivery, or transfer to the&#xD;
      NICU, and notification by the neonatology service. Infants born at less than 30 weeks&#xD;
      gestational age, birth weight less than or equal to 1500 grams will be eligible for&#xD;
      enrollment in the study. The purpose of the study designed is to compare the splanchnic&#xD;
      tissue oxygenation index and gut inflammatory biomarkers of patients with any stage of NEC&#xD;
      with healthy controls. Since we will not be able to determine which patients will develop NEC&#xD;
      a priori, we will anticipate enrolling up to 450 neonates to identify 15 neonates with NEC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 6, 2017</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>splanchnic tissue oxygenation in population at high risk for NEC</measure>
    <time_frame>2022</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Necrotizing Enterocolitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        low birth weight, preterm infants&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infants born at ≤30 weeks gestational age and/or&#xD;
&#xD;
          -  Infants with a birth weight ≤1500 grams&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  gestational age at birth greater than 30 weeks&#xD;
&#xD;
          -  obvious dysmorphic syndromes&#xD;
&#xD;
          -  any abdominal wall defect including omphalocele or gastroschisis&#xD;
&#xD;
          -  any known intestinal atresia&#xD;
&#xD;
          -  complex cardiac abnormalities&#xD;
&#xD;
          -  any known lethal chromosomal abnormalities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Candace C Style, MD</last_name>
    <phone>614-355-3686</phone>
    <email>candace.style@nationwidechildrens.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alicia Menchaca, MD</last_name>
    <phone>810-841-9966</phone>
    <email>Alicia.Menchaca@nationwidechildrens.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candace C Style, MD</last_name>
      <email>candace.style@nationwidechildrens.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 5, 2017</study_first_submitted>
  <study_first_submitted_qc>July 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Oluyinka Olutoye, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>NEC, tissue oxygenation, gut inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

